Puma Biotechnology, Inc. Just Beat EPS By 278%: Here's What Analysts Think Will Happen Next [Yahoo! Finance]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Yahoo! Finance
The company beat forecasts, with revenue of US$55m, some 6.9% above estimates, and statutory earnings per share (EPS) coming in at US$0.17, 278% ahead of expectations. Following the result, the analyst has updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analyst is expecting for next year. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. NasdaqGS:PBYI Earnings and Revenue Growth November 9th 2025 Taking into account the latest results, the most recent consensus for Puma Biotechnology from sole analyst is for revenues of US$220.0m in 2026. If met, it would imply a satisfactory 3.8% increase on its revenue over the past 12 months. Statutory earnings per share are expected to plunge 39% to US$0.45 in the same period. In the l
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology: Step By Step In Making A Transition [Seeking Alpha]Seeking Alpha
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Puma Biotechnology Reports Third Quarter 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
PBYI
Earnings
- 11/6/25 - Beat
PBYI
Sec Filings
- 11/12/25 - Form 144
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- PBYI's page on the SEC website